Angelman Syndrome clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Long-term Extension of GTX-102 in Angelman Syndrome
Sorry, accepting new patients by invitation only
The primary objective of the study is to evaluate the long-term safety profile of GTX-102 in participants with Angelman Syndrome (AS)
Los Angeles 5368361, California 5332921 and other locations
Our lead scientists for Angelman Syndrome research studies include Rajsekar R. Rajaraman, MD, MS.
Last updated: